CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) genotyping and its influence on breast cancer treatment by tamoxifen indicate the importance of personalized medicine in treating patients [6]. Here, CYP2D6 is linked to breast cancer.